Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2021

View Archived Issues

Researchers develop useful murine model of Bardet-Biedl syndrome

MDM2 and MDMX have a p53-independent role in cell-cycle progression in the absence of wild-type p53

Unveiling the evolutionary acquisition of antifungal drug resistance in Candida glabrata

QIMR describes CAR-T cells derived from CD49f+ T cells

Aptamer Sciences patents insulin receptor-specific aptamers

New HSD17B13 inhibitors identified at Inipharm

Glucagon receptor agonists discovered at Intarcia Therapeutics

Prelude Therapeutics presents new Mcl-1 inhibitors

Virulent factors of P. aeruginosa isolates are upregulated under anaerobic conditions

PKM2 is a novel regulator of brown fat adipogenesis

L-WNK1 inhibition as novel therapeutic strategy for protection from glomerular injury

ADX-097 displays targeted complement inhibition in tissues

Brain infections rare but brain symptoms common with SARS-CoV-2

CG-223 demonstrates antifibrotic effects in a murine model of pulmonary fibrosis

Cocrystal Pharma reports pan-viral activity of SARS-CoV-2 main protease inhibitors

MC4 receptor induces antipsychotic drug-related metabolic syndrome

PDS Biotechnology licenses rights to proprietary TARP antigen from NCI

Cybin reports positive preclinical data on deuterated psilocybin analogue

Verve announces preclinical data on GalNAc-LNP technology to deliver ANGPTL3 base editor in NHPs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...